The Weill Cornell Medicine Comprehensive Thalassemia Center staff members are committed to the safety and well-being of our patients. For more information about COVID-19, here are links to other sources: the Weill Cornell COVID-19 patient guide, the Centers for Disease Control (CDC) website, the NYC Department of Health website, and the Cooley's Anemia Foundation website. These sources provide up-to-date information on signs and symptoms, precautions to take, when to quarantine and other important tips. If you have developed a fever, cough, shortness of breath or other respiratory symptoms, please call your provider right away.
New York Comprehensive Thalassemia Center

For Providers

As one of the longest-standing thalassemia care centers in the country, we possess extensive experience and treatment expertise. The Weill Cornell Medicine New York Comprehensive Thalassemia Center is trusted to provide up-to-date guidelines as well as support for hematologists and primary care providers. We also have a rich history of participating in and conducting clinical trials, resulting in major care advancements in care and outcome improvements through a reduction in morbidity. 


Guidelines developed at the New York Comprehensive Thalassemia Center, based on review of available literature and our own experience, include:

  • Guidelines for Transfusion-Dependent Thalassemia (TDT) Transfusion Therapy
  • Guidelines for Comprehensive Thalassemia Monitoring
  • Guidelines for Thalassemia Chelation (Transfusion-Dependent and Non-Transfusion-Dependent Patients)
  • Guidelines for Thalassemia Patient Pregnancy Management

New York Comprehensive Thalassemia Center of Weill Cornell Medicine 525 E. 68th St.
Payson 695
New York, NY 10065 Phone: (212) 746-3400